These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28040737)

  • 1. A systematic review of economic evaluations of screening programmes for cardiometabolic diseases.
    Hiligsmann M; Wyers CE; Mayer S; Evers SM; Ruwaard D
    Eur J Public Health; 2017 Aug; 27(4):621-631. PubMed ID: 28040737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of screening for hepatitis C virus: a systematic review of economic evaluations.
    Coward S; Leggett L; Kaplan GG; Clement F
    BMJ Open; 2016 Sep; 6(9):e011821. PubMed ID: 27601496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective.
    Ferguson TW; Tangri N; Tan Z; James MT; Lavallee BDA; Chartrand CD; McLeod LL; Dart AB; Rigatto C; Komenda PVJ
    Kidney Int; 2017 Jul; 92(1):192-200. PubMed ID: 28433383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection.
    Campbell JR; Sasitharan T; Marra F
    Appl Health Econ Health Policy; 2015 Aug; 13(4):325-40. PubMed ID: 26129810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and economic evaluation of exercise referral schemes in primary care: a short report.
    Campbell F; Holmes M; Everson-Hock E; Davis S; Buckley Woods H; Anokye N; Tappenden P; Kaltenthaler E
    Health Technol Assess; 2015 Jul; 19(60):1-110. PubMed ID: 26222987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluations of adult weight management interventions: a systematic literature review focusing on methods used for determining health impacts.
    Griffiths UK; Anigbogu B; Nanchahal K
    Appl Health Econ Health Policy; 2012 May; 10(3):145-62. PubMed ID: 22439628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Evaluations of Multicomponent Disease Management Programs with Markov Models: A Systematic Review.
    Kirsch F
    Value Health; 2016 Dec; 19(8):1039-1054. PubMed ID: 27987631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
    Go DS; Kim SH; Park J; Ryu DR; Lee HJ; Jo MW
    Nephrology (Carlton); 2019 Jan; 24(1):56-64. PubMed ID: 29206319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
    Haasova M; Snowsill T; Jones-Hughes T; Crathorne L; Cooper C; Varley-Campbell J; Mujica-Mota R; Coelho H; Huxley N; Lowe J; Dudley J; Marks S; Hyde C; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design.
    Sugrue DM; Ward T; Rai S; McEwan P; van Haalen HGM
    Pharmacoeconomics; 2019 Dec; 37(12):1451-1468. PubMed ID: 31571136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
    Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
    BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
    Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A
    Value Health; 2010; 13(2):196-208. PubMed ID: 19878493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
    Jones-Hughes T; Snowsill T; Haasova M; Coelho H; Crathorne L; Cooper C; Mujica-Mota R; Peters J; Varley-Campbell J; Huxley N; Moore J; Allwood M; Lowe J; Hyde C; Hoyle M; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(62):1-594. PubMed ID: 27578428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.
    van Giessen A; Boonman-de Winter LJ; Rutten FH; Cramer MJ; Landman MJ; Liem AH; Hoes AW; Koffijberg H
    Cardiovasc Diabetol; 2016 Mar; 15():48. PubMed ID: 27001409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for proteinuria in US adults: a cost-effectiveness analysis.
    Boulware LE; Jaar BG; Tarver-Carr ME; Brancati FL; Powe NR
    JAMA; 2003 Dec; 290(23):3101-14. PubMed ID: 14679273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney disease.
    Wang H; Yang L; Wang F; Zhang L
    BMC Nephrol; 2017 Apr; 18(1):135. PubMed ID: 28420333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease.
    Okubo R; Kondo M; Hoshi SL; Yamagata K
    Sleep Breath; 2015 Sep; 19(3):1081-92. PubMed ID: 25643768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.
    Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME;
    BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature.
    Skally M; Hanly P; Sharp L
    Appl Health Econ Health Policy; 2013 Jun; 11(3):181-92. PubMed ID: 23549792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.